Search | TVST | ARVO Journals

Showing 1 – 15 of 15

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Clinical Trials September 2023

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration

PDF

Clement K. Chan; Wesley T. Beaulieu; Brandon J. Lujan; Maziar Lalezary; Daniella Lent-Schochet; Therlinder Lo; Glenn Yiu
TAGS: age-related macular degeneration, exudative age-related macular degeneration, eye, ranibizumab, drusen, injections, volume, spectral domain-optical coherence tomography
Trans. Vis. Sci. Tech.. 2023; 12(9):1. https://doi.org/10.1167/tvst.12.9.1

Includes: Supplemental Content

Special Issue October 2021

One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration

PDF

Amir H. Kashani; Jane S. Lebkowski; Firas M. Rahhal; Robert L. Avery; Hani Salehi-Had; Sanford Chen; Clement Chan; Neal Palejwala; April Ingram; Wei Dang; Chih-Min Lin; Debbie Mitra; Britney O. Pennington; Cassidy Hinman; Mohamed A. Faynus; Jeffrey K. Bailey; Sukriti Mohan; Narsing Rao; Lincoln V. Johnson; Dennis O. Clegg; David R. Hinton; Mark S. Humayun
TAGS: age-related macular degeneration, follow-up, implants, retinal pigment cell, surgical procedures, operative, postoperative care, therapeutic immunosuppression
Trans. Vis. Sci. Tech.. 2021; 10(10):13. https://doi.org/10.1167/tvst.10.10.13

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

A Randomized Clinical Trial of Pneumatic Vitreolysis with C 3 F 8 for Vitreomacular Traction and A Single-Arm Study of Pneumatic Vitreolysis with C 3 F 8 for Macular Hole: DRCR Retina Network Protocols AG and AH

Clement K Chan; Calvin E Mein; DRCR Retina Network

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3667.

ARVO Annual Meeting Abstract July 2018

Managing focal vitreomacular traction with pneumatic vitreolysis, an emerging surgical technique

Martha Henao; Calvin Mein; Moises Chica; Gary Lane; Clement K Chan

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5268.

ARVO Annual Meeting Abstract June 2017

Pneumatic Vitreolysis (PVL) for the Treatment of Vitreomacular Traction Syndrome (VMT)

Calvin E Mein; Clement K Chan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3688.

ARVO Annual Meeting Abstract June 2017

Prophylactic Ranibizumab for Exudative age-related macular degeneration (AMD) in Vulnerable Eyes with Non-Exudative AMD Trial (PREVENT): A prospective controlled clinical trial

Maziar Lalezary; Steven G. Lin; Clement K Chan; Bansal S. Alok; Rahul N Khurana; Mark Wieland; Louis K Chang; James Palmer; Prema Abraham; Michael J Elman; Brandon J Lujan; Glenn Yiu

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):410.

ARVO Annual Meeting Abstract June 2017

Frequency of the C3 Gly102 risk variant is higher in AMD patients with Geographic Atrophy compared to patients with Vascular Pigment Epithelial Detachment

Clement K Chan; Prema Abraham; Andre D Hafner; Lorah T Perlee

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1837.

ARVO Annual Meeting Abstract June 2015

Prospective Multimodal Analysis of Aflibercept treatment of Pigment Epithelial Detachment in Neovascular AMD: The Even Study.

Clement K Chan; David Sarraf; Prema Abraham; Maziar Lalezary; Steven Lin; EVEN Study Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4598.

ARVO Annual Meeting Abstract April 2014

Pneumatic Maculopexy: A Novel Approach for Treatment of Symptomatic Vitreomacular Traction

Calvin Einar Mein; Clement K Chan

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):300.

ARVO Annual Meeting Abstract April 2014

Results at Six Months after Conversion to Aflibercept for Patients on Prior Ranibizumab or Bevacizumab Treatment for Exudative Age-Related Macular Degeneration

Clement K Chan; Atul Jain; Srinivas R Sadda; Neeta Varshney; ANTI-VEGF TRANSITION STUDY GROUP FOR AMD

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3948.

ARVO Annual Meeting Abstract April 2014

The EVEN Study: An In-depth Prospective Trial on Intravitreal Aflibercept Treatment of Submacular Vascularized Pigment Epithelial Detachment

Maziar Lalezary; David Sarraf; Prema Abraham; Steven G Lin; Clement K Chan; EVEN Study Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3969.

ARVO Annual Meeting Abstract June 2013

Genotype Analysis for Single Nucleotide Polymorphisms Profile of Eyes with Vascularized Pigment Epithelial Detachment due to AMD

Clement Chan; David Sarraf; Prema Abraham; Duy Nguyen; Steven Lin; Maziar Lalezary; Kang Zhang; VPED Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6184.

ARVO Annual Meeting Abstract March 2012

Comparing Outcomes of 0.5 vs. 2.0 mg Ranibizumab Treatment in Eyes with Vascularized Pigment Epithelial Detachment based on Lesion Subtypes (Serous Vascularized Pigment Epithelial Detachment vs. Fibrovascular Pigment Epithelial Detachment) associated with AMD

Clement K. Chan; David Sarraf; prema Abraham; Asha S. Nuthi; Steven G. Lin; Colin A. McCannel

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5149.

ARVO Annual Meeting Abstract April 2011

The Burden Of Refractive Error In China

Danny S. Ng; Clement W. Chan; Mingguang He; Leon Ellwein; Jialiang Zhao; Paul Glewwe; Xiang Lu; Ningli Wang; Benita O'Colmain; Nathan G. Congdon

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2520.

ARVO Annual Meeting Abstract April 2011

High versus Conventional-dose Ranibizumab for Treating Vascularized Pigment Epithelial Detachments Associated with Age-related Macular Degeneration

Clement K. Chan; Prema Abraham; David Sarraf; Asha S. Nuthi; Steven G. Lin; Colin A. McCannel; Sharon McCaffery-Theodore

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):1654.

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration

One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration

A Randomized Clinical Trial of Pneumatic Vitreolysis with C 3 F 8 for Vitreomacular Traction and A Single-Arm Study of Pneumatic Vitreolysis with C 3 F 8 for Macular Hole: DRCR Retina Network Protocols AG and AH

Managing focal vitreomacular traction with pneumatic vitreolysis, an emerging surgical technique

Pneumatic Vitreolysis (PVL) for the Treatment of Vitreomacular Traction Syndrome (VMT)

Prophylactic Ranibizumab for Exudative age-related macular degeneration (AMD) in Vulnerable Eyes with Non-Exudative AMD Trial (PREVENT): A prospective controlled clinical trial

Frequency of the C3 Gly102 risk variant is higher in AMD patients with Geographic Atrophy compared to patients with Vascular Pigment Epithelial Detachment

Prospective Multimodal Analysis of Aflibercept treatment of Pigment Epithelial Detachment in Neovascular AMD: The Even Study.

Pneumatic Maculopexy: A Novel Approach for Treatment of Symptomatic Vitreomacular Traction

Results at Six Months after Conversion to Aflibercept for Patients on Prior Ranibizumab or Bevacizumab Treatment for Exudative Age-Related Macular Degeneration

The EVEN Study: An In-depth Prospective Trial on Intravitreal Aflibercept Treatment of Submacular Vascularized Pigment Epithelial Detachment

Genotype Analysis for Single Nucleotide Polymorphisms Profile of Eyes with Vascularized Pigment Epithelial Detachment due to AMD

Comparing Outcomes of 0.5 vs. 2.0 mg Ranibizumab Treatment in Eyes with Vascularized Pigment Epithelial Detachment based on Lesion Subtypes (Serous Vascularized Pigment Epithelial Detachment vs. Fibrovascular Pigment Epithelial Detachment) associated with AMD

The Burden Of Refractive Error In China

High versus Conventional-dose Ranibizumab for Treating Vascularized Pigment Epithelial Detachments Associated with Age-related Macular Degeneration

To View More...

You must be signed into an individual account to use this feature.